Synthesis, characterization and cholinesterase enzymes inhibitory activity of 1-[3-methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-4,5-dihydro-pyrazol-1-yl]-ethanone

The twisting of the cyclohexene ring relative to the pyrazole one gives rise to a medium intense intramolecular interaction of a methyl hydrogen of the former with the centroid of the latter. [Display omitted] •1-[3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-4,5-dihydro-pyrazol-1-yl]-ethanone was sy...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular structure Vol. 1049; pp. 488 - 493
Main Authors Mehdi, Sayed Hasan, Ghalib, Raza Murad, Hashim, Rokiah, da Silva, M. Fátima C. Guedes, Sulaiman, Othman, Murugaiyah, Vikneswaran, Marimuthu, Mani Maran, Naqvi, Mehnaz
Format Journal Article
LanguageEnglish
Published Elsevier B.V 08.10.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The twisting of the cyclohexene ring relative to the pyrazole one gives rise to a medium intense intramolecular interaction of a methyl hydrogen of the former with the centroid of the latter. [Display omitted] •1-[3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-4,5-dihydro-pyrazol-1-yl]-ethanone was synthesized.•X-ray crystallography, 1H, 13CNMR and IR spectral studies confirmed the structure.•Inhibitory activity against acetylcholinesterase and butyrylcholinesterase enzyme. The crystal structure of the title compound, 1-[3-methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-4,5-dihydro-pyrazol-1-yl]-ethanone has been determined by single crystal X-ray diffraction. It crystallizes in the orthorhombic space group P212121. The FTIR as well as the 1H and 13C NMR spectra of the compound were also recorded and briefly discussed. Compound 1 demonstrated good inhibitory activity against butyrylcholinesterase (BChE; IC50=46.42μM) comparable to physostigmine. However it showed moderate inhibitory activity against acetylcholinesterase (AChE; IC50=157.31μM). It showed moderate inhibitory activity against acetylcholinesterase and selective inhibitory activity towards butyrylcholinesterase enzyme.
Bibliography:http://dx.doi.org/10.1016/j.molstruc.2013.06.049
ISSN:0022-2860
1872-8014
DOI:10.1016/j.molstruc.2013.06.049